ACAA2

acetyl-CoA acyltransferase 2

Basic information

Region (hg38): 18:49782164-49813953

Links

ENSG00000167315NCBI:10449OMIM:604770HGNC:83Uniprot:P42765AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ACAA2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACAA2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
22
clinvar
2
clinvar
1
clinvar
25
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
Total 0 0 22 3 1

Variants in ACAA2

This is a list of pathogenic ClinVar variants found in the ACAA2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
18-49783909-C-G not specified Uncertain significance (Nov 07, 2022)2269308
18-49783909-C-T not specified Likely benign (Jun 21, 2022)2208325
18-49783920-C-G not specified Uncertain significance (Jan 10, 2023)2465769
18-49783926-C-A not specified Uncertain significance (Jul 20, 2021)2238739
18-49783930-G-A not specified Uncertain significance (Nov 15, 2023)3133392
18-49785204-C-T not specified Uncertain significance (Dec 21, 2022)2355213
18-49785245-A-T not specified Uncertain significance (Jul 07, 2022)2299955
18-49787272-A-AC Likely benign (Dec 30, 2023)2975911
18-49787302-C-A not specified Uncertain significance (Apr 01, 2024)3260303
18-49787309-C-G not specified Uncertain significance (Apr 28, 2022)2215967
18-49791473-T-C not specified Uncertain significance (Jul 14, 2023)2597112
18-49791553-G-C not specified Uncertain significance (Sep 17, 2021)2251475
18-49791586-C-T not specified Uncertain significance (Mar 19, 2024)3260293
18-49791596-C-T not specified Likely benign (Mar 05, 2024)3133436
18-49792157-C-T not specified Uncertain significance (May 02, 2024)3260313
18-49792193-C-T not specified Uncertain significance (May 04, 2022)2227536
18-49792255-A-G not specified Uncertain significance (Sep 22, 2022)2313093
18-49792289-T-C not specified Uncertain significance (May 31, 2022)3133429
18-49792313-A-T Benign (Oct 17, 2017)726897
18-49794310-C-T not specified Uncertain significance (May 31, 2023)2554633
18-49794412-A-G not specified Uncertain significance (Mar 17, 2023)2522252
18-49795784-T-G not specified Uncertain significance (May 03, 2023)2542649
18-49795809-C-T not specified Uncertain significance (Jul 28, 2021)2389583
18-49795814-T-C not specified Uncertain significance (Oct 26, 2022)2319912
18-49795868-T-C not specified Uncertain significance (Jan 24, 2024)3133409

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ACAA2protein_codingprotein_codingENST00000285093 1030462
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.71e-100.1811256610871257480.000346
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.2712202091.050.00001042551
Missense in Polyphen9284.8241.0846988
Synonymous0.8976372.70.8660.00000375805
Loss of Function0.5591618.60.8609.33e-7248

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.002270.00228
Ashkenazi Jewish0.00009920.0000992
East Asian0.0001630.000163
Finnish0.00009250.0000924
European (Non-Finnish)0.0002210.000220
Middle Eastern0.0001630.000163
South Asian0.0002620.000261
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Abolishes BNIP3-mediated apoptosis and mitochondrial damage. {ECO:0000269|PubMed:18371312}.;
Pathway
Fatty acid degradation - Homo sapiens (human);Fatty acid elongation - Homo sapiens (human);Valine, leucine and isoleucine degradation - Homo sapiens (human);Long chain acyl-CoA dehydrogenase deficiency (LCAD);3-Methylglutaconic Aciduria Type I;Valine, Leucine and Isoleucine Degradation;2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency;Trifunctional protein deficiency;Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD);Carnitine palmitoyl transferase deficiency (II);Very-long-chain acyl coa dehydrogenase deficiency (VLCAD);Medium chain acyl-coa dehydrogenase deficiency (MCAD);Fatty Acid Elongation In Mitochondria;Isovaleric Aciduria;3-Methylcrotonyl Coa Carboxylase Deficiency Type I;Propionic Acidemia;Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency);Fatty acid Metabolism;Maple Syrup Urine Disease;3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency;Isobutyryl-coa dehydrogenase deficiency;3-hydroxyisobutyric aciduria;3-hydroxyisobutyric acid dehydrogenase deficiency;Isovaleric acidemia;Glutaric Aciduria Type I;Ethylmalonic Encephalopathy;Methylmalonate Semialdehyde Dehydrogenase Deficiency;Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids;Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids;Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids;Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD);Methylmalonic Aciduria;3-Methylglutaconic Aciduria Type IV;3-Methylglutaconic Aciduria Type III;Beta-Ketothiolase Deficiency;Carnitine palmitoyl transferase deficiency (I);miR-targeted genes in epithelium - TarBase;miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;miR-targeted genes in squamous cell - TarBase;Fatty Acid Biosynthesis;Liver steatosis AOP;Metabolism of lipids;Mitochondrial Fatty Acid Beta-Oxidation;3-oxo-10R-octadecatrienoate beta-oxidation;Leukotriene metabolism;Saturated fatty acids beta-oxidation;Metabolism;Fatty acid metabolism;Propanoate metabolism;Mono-unsaturated fatty acid beta-oxidation;Omega-6 fatty acid metabolism;Valine, leucine and isoleucine degradation;Dimethyl-branched-chain fatty acid mitochondrial beta-oxidation;Di-unsaturated fatty acid beta-oxidation;Vitamin E metabolism;fatty acid β-oxidation (peroxisome);fatty acid β-oxidation;bile acid biosynthesis, neutral pathway;Valine Leucine Isoleucine degradation (Consensus)

Recessive Scores

pRec
0.366

Intolerance Scores

loftool
0.307
rvis_EVS
-0.58
rvis_percentile_EVS
18.72

Haploinsufficiency Scores

pHI
0.175
hipred
N
hipred_score
0.319
ghis
0.543

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.0135

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Acaa2
Phenotype

Gene ontology

Biological process
fatty acid beta-oxidation;cholesterol biosynthetic process;cellular response to hypoxia;negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;negative regulation of mitochondrial membrane permeability involved in apoptotic process
Cellular component
mitochondrion;mitochondrial matrix
Molecular function
RNA binding;acetyl-CoA C-acetyltransferase activity;acetyl-CoA C-acyltransferase activity;protein binding